ADD-How important is the FDA approval of once weekly dosage of Kyprolis for multiple myeloma patients? - 101867

Spotlight
Video

ADD-How important is the FDA approval of once weekly dosage of Kyprolis for multiple myeloma patients?

Loading........
Description: In this week’s video, Dr. Brian G.M. Durie explains the results of the A.R.R.O.W. trial, which proved the efficacy and safety of once-a-week dosing of Kyprolis for myeloma patients.

BOTTOM LINE:
The FDA approval of once-weekly dosing of Kyprolis is effective, more convenient for patients, and doesn’t lead to additional toxicities.
Shared By : InternationalMyelomaFoundation
Posted on : 11/13/18
Added : 7 months ago
Category : Multiple Myeloma